Buy Drugs Online:
Drugs Information:
Drugs List

1. Name Of The Medicinal Product

Isotrexin Gel

2. Qualitative And Quantitative Composition

Active Ingredient  
Isotretinoin 0.05%w/w
Erythromycin 2.00%w/w
1 g Gel contains:  
Isotretinoin 0.5mg
Erythromycin 20.mg

For excipients, see 6.1.

3. Pharmaceutical Form

Gel

A pale yellow soft gel.

4. Clinical Particulars

4.1 Therapeutic Indications

Isotrexin is indicated for the topical treatment of moderate acne.

4.2 Posology And Method Of Administration

Adults

Apply Isotrexin sparingly over the entire affected area once or twice daily, preferably after cleaning the skin.

Patients should be advised that, in some cases, six to eight weeks of treatment may be required before the full therapeutic effect is observed.

Patients should wash their hands after application of Isotrexin Gel.

The patient should be advised to avoid over-satur

1. Name Of The Medicinal Product

INFLEXAL V

Suspension for injection

Influenza vaccine (surface antigen, inactivated, virosome)

Season 2011/2012

2. Qualitative And Quantitative Composition

Influenza virus surface antigens (haemagglutinin and neuraminidase), virosome, of the following strains*:

A/California/7/2009 (H1N1) derived strain used (NYMC X-181)

15 micrograms HA**

A/Perth/16/2009 (H3N2)-like strain used (NYMC X-187 derived from A/Victoria/210/2009)

15 micrograms HA**

B/Brisbane/60/2008

15 micrograms HA**

per 0.5 ml dose

* propagated in fertilised hen's eggs from healthy chicken flocks

** haemagglutinin

Inflexal V is an inactivated influenza vaccine formulated with virosomes as carrier/adjuvant system, composed of highly purified surface antigens of strain A and B of the influenza virus propagated in fertilized hen's eggs.

This vaccine complies with the WHO recommendation (Northern hemisphere) and EU decision for the 2011/2012 season.

For a full list of excipients see section 6.1

3. Pharmaceutical Form

Suspension for injection.

Slightly opalescent liquid.

Supplied in a pre-filled syringe.

4. Clinical Particulars

4.1 Therapeutic Indications

Prophylaxis of influenza, especially in those who run an increased risk of associated complications.

The use of Inflexal V should be based on official recommendations.

4.2 Posology And Method Of Administration

Adults and children from 36 months: 0.5 ml.

Children from 6 months to 35 months:

1. Name Of The Medicinal Product

Isotretinoin 5mg Capsules

Rizuderm 5mg Capsules

2. Qualitative And Quantitative Composition

Each capsule contains 5mg isotretinoin

For excipients, see section 6.1

3. Pharmaceutical Form

Soft capsules.

Red/orange soft gelatin capsules marked 'P5'

4. Clinical Particulars

4.1 Therapeutic Indications

Isotretinoin capsules are indicated for the treatment of severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring), resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy.

4.2 Posology And Method Of Administration

Isotretinoin should only be prescribed by or under the supervision of physicians with expertise in the use of systemic retinoids for the treatment of severe acne and a full understanding of the risks of isotretinoin therapy and monitoring requirements.

The capsules should be taken with food once or twice daily.

Adults including adolescents and the elderly:

Isotretinoin therapy should be started at a dose of 0.5 mg/kg daily. The therapeutic response to isotretinoin and some of the adverse effects are dose-related and vary between patients. This necessitates individual dosage adjustment during therapy. For most patients, the dose ranges from 0.5-1.0 mg/kg per day.

Long-term remission and relapse rates are more closely related to the total dose administered than to either duration of treatment or daily dose. It has been shown that no substantial additional benefit is to be expected beyond a cumulative treatment dose of 120-150 mg/kg. The duration of treatment will depend on the indivi

1. Name Of The Medicinal Product

Imipramine Hydrochloride 25mg/5ml Oral Solution

2. Qualitative And Quantitative Composition

Imipramine hydrochloride (N-(?-dimethylaminopropyl)-iminodibenzyl hydrochloride) 25mg / 5ml in an oral solution formulation

Each 5ml of solution also contains;

Sorbitol (E420)

1500.0 mg

 

Methylhydroxy benzoate (E218)

6.85 mg

 

Propylhydroxy benzoate (E216)

0.57 mg

 

For a full list of excipients, see section 6.1

3. Pharmaceutical Form

Oral Solution

A clear colourless banana flavoured solution.

4. Clinical Particulars

4.1 Therapeutic Indications

Symptoms of depressive illness. Relief of nocturnal enuresis in children.

4.2 Posology And Method Of Administration

Depression:

Adults: 1 x 25mg up to three times daily, increasing stepwise to 150-200mg. This should be reached by the end of the first week and maintained u

1. Name Of The Medicinal Product

ISTIN™ 5 mg tablets

ISTIN™ 10 mg tablets

2. Qualitative And Quantitative Composition

Each tablet contains amlodipine besilate equivalent to 5mg amlodipine

Each tablet contains amlodipine besilate equivalent to 10mg amlodipine

Excipients:

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

5 mg tablets: White to off-white, emerald shaped tablets engraved AML 5 and breaker score on one side and Pfizer logo on the other side.

The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

10mg tablets: White to off-white, emerald-shaped tablets engraved AML-10 on one side and Pfizer logo on the other side.

4. Clinical Particulars

4.1 Therapeutic Indications

Hypertension

Chronic stable angina pectoris

Vasospastic (Prinzmetal's) angina

4.2 Posology And Method Of Administration

Posology

Adults

For both hypertension and angina the usual initial dose is 5 mg Istin once daily which may be increased to a maximum dose of 10 mg depending on the individual patient's response.

In hypertensive patients, Istin has been used in combination with a thiazide diuretic, alpha blocker, beta blocker, or an angiotensin converting enzyme inhibitor. For angina, Istin may be used as monotherapy or in combination with other antianginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta blockers.

No dose adjustment of Istin is required upon concomitant administration of thiazide diuretics, beta blockers, and angiotensin-converting

INVANZ 1 g powder for concentrate for solution for infusion

(ertapenem)

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or your pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or your pharmacist.

In this leaflet:

1. What INVANZ is and what it is used for
2. Before you take INVANZ
3. How to take INVANZ
4. Possible side effects
5. How to store INVANZ
6. Further information

What Invanz Is And What It Is Used For

INVANZ is an injectable antibiotic which will always be prepared and given to you by a doctor or another healthcare professional.

INVANZ contains ertapenem which is an antibiotic of the beta-lactam group. It has the ability to kill a wide range of bacteria (germs) that cause infections in various parts of the body.

Treatment:

Your doctor has prescribed INVANZ because you have one (or more) of the following types of infection:

  • Infection in the abdomen
  • Infection affecting the lungs (pneumonia)
  • Gynaecological infections
  • Skin infections of the foot in diabetic patients.

Prevention:

  • Prevention of surgical site infections follow

influvac sub - unit

Influvac Sub-unit, suspension for injection in prefilled syringe

Influenza vaccine (surface antigen, inactivated)

Read all of this leaflet carefully before you or your child is vaccinated.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This vaccine has been prescribed for you or your child. Do not pass it on to others.
  • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

In this leaflet

  • 1 WHAT INFLUVAC IS AND WHAT IT IS USED FOR
  • 2 BEFORE YOU OR YOUR CHILD USE INFLUVAC
  • 3 HOW TO USE INFLUVAC
  • 4 POSSIBLE SIDE EFFECTS
  • 5 HOW TO STORE INFLUVAC
  • 6 FURTHER INFORMATION

What Influvac Is And What It Is Used For

Influvac is a vaccine. This vaccine helps to protect you or your child against influenza (flu), particularly in subjects who run a high risk of associated complications. The use of Influvac should be based on official recommendations.

When a person is given the vaccine Influvac, the immune system (the body’s natural defence system) will produce its own protection (antibodies) against the disease. None of the ingredients in the vaccine can cause flu.

Flu is a disease that can spread rapidly and is caused by different types of strains that can

1. Name Of The Medicinal Product

IMODIUM PLUS CAPLET

2. Qualitative And Quantitative Composition

Each tablet contains loperamide hydrochloride 2 mg and simeticone equivalent to 125 mg dimeticone.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Tablet, uncoated

White, capsule-shaped tablets debossed with “IMO” on one side, the other side is debossed with a line between “2and 125.

4. Clinical Particulars

4.1 Therapeutic Indications

Imodium Plus Caplets are indicated for the symptomatic treatment of acute diarrhoea in adults and adolescents over 12 years when acute diarrhoea is associated with gas-related abdominal discomfort including bloating, cramping or flatulence.

4.2 Posology And Method Of Administration

The tablets should be taken with liquid.

Adults over 18 years:

Take two caplets initially, followed by one caplet after every loose stool. Not more than 4 caplets should be taken in a day, limited to no more than 2 days.

Adolescents between 12 and 18 years:

Take one caplet initially, followed by one caplet after every loose stool. Not more than 4 caplets should be taken in a day, limited to no more than 2 days.

Use in children:

Imodium Plus must not be used in children under 12 years.

Use in the elderly:

No dosage adjustments are required for the elderly.

Use in renal impairment:

No dosage adjustment

1. Name Of The Medicinal Product

Instanyl 50 micrograms nasal spray, solution in single-dose container

Instanyl 100 micrograms nasal spray, solution in single-dose container

Instanyl 200 micrograms nasal spray, solution in single-dose container

2. Qualitative And Quantitative Composition

Each nasal spray container contains one dose (100 microlitres) of fentanyl citrate equivalent to 50 micrograms fentanyl.

Each nasal spray container contains one dose (100 microlitres) of fentanyl citrate equivalent to 100 micrograms fentanyl.

Each nasal spray container contains one dose (100 microlitres) of fentanyl citrate equivalent to 200 micrograms fentanyl.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Nasal spray, solution (nasal spray)

Clear, colourless solution.

4. Clinical Particulars

4.1 Therapeutic Indications

Instanyl is indicated for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.

Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.

4.2 Posology And Method Of Administration

Treatment should be initiated by and remain under the supervision of a physician experienced in the management of opioid therapy in cancer patients. Physicians should keep in mind t

1. Name Of The Medicinal Product

2. Qualitative And Quantitative Composition

One vial contains 150 mg of canakinumab*.

After reconstitution, each ml of solution contains 150 mg canakinumab.

* fully human monoclonal antibody produced in mouse hybridoma Sp2/0 cells by recombinant DNA technology

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Powder for solution for injection.

The powder is white.

4. Clinical Particulars

4.1 Therapeutic Indications

Ilaris is indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) in adults, adolescents and children aged 4 years and older with body weight above 15 kg, including:

? Muckle-Wells Syndrome (MWS),

? Neonatal-Onset Multisystem Inflammatory Disease (NOMID) / Chronic Infantile Neurological, Cutaneous, Articular Syndrome (CINCA),

? Severe forms of Familial Cold Autoinflammatory Syndrome (FCAS) / Familial Cold Urticaria (FCU) presenting with signs and symptoms beyond cold-induced urticarial skin rash.

4.2 Posology And Method Of Administration

Treatment should be initiated and supervised by a specialist physician experienced in the diagnosis and treatment of CAPS.

After proper training in the correct injection technique, patients may self-inject Ilaris if their physician determines that it is appropriate and with medical follow-up as necessary.

Adults, adolescents and children aged 4 years and older

The recommended dose of Ilaris is 150 mg for CAPS patients with body weight > 40 kg and 2 mg/kg for CAPS patients with body weight

If a satisfactory clini

Boots Ibuprofen Caplets 200 mg

Read all of this leaflet carefully because it contains important information for you.

This medicine is available without prescription to treat minor conditions. However, you still need to take it carefully to get the best results from it.

  • Keep this leaflet, you may need to read it again
  • Ask your pharmacist if you need more information or advice

What this medicine is for

This medicine contains ibuprofen which belongs to a group called non-steroidal anti-inflammatory medicines, which act to relieve pain and reduce swelling. It can be used to relieve headaches, rheumatic and muscular pain, pain from non-serious arthritic conditions, backache, migraine, period pain, dental pain and neuralgia. It can also be used to reduce fever and relieve the symptoms of colds and flu.

Before you take this medicine

This medicine can be taken by adults and children aged 12 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or doctor first.

Do not take:

  • If you have a stomach ulcer, perforation or bleeding, or have had one twice or more in the past
  • If you have had perforation or a bleeding stomach after taking a non-steroidal anti-inflammatory medicine (you may have been sick and it contained blood or dark particles that look like coffee grounds, passed blood in your stools or passed black tarry stools)
  • If you are allergic to ibuprofen or any other ingredients of the product, aspirin o

1. Name Of The Medicinal Product

Imodium™ Liquid

2. Qualitative And Quantitative Composition

Loperamide hydrochloride Ph Eur 1 mg per 5 ml.

3. Pharmaceutical Form

Oral liquid.

4. Clinical Particulars

4.1 Therapeutic Indications

For the treatment of acute diarrhoea.

For the symptomatic treatment of acute episodes of diarrhoea associated with irritable bowel syndrome in adults following initial diagnosis by a doctor.

4.2 Posology And Method Of Administration

For adults and children 12 years and over:

4 mg initially (20 ml) and then 2 mg (10 ml) after each loose stool.

Symptomatic treatment of acute episodes of diarrhoea associated with irritable bowel syndrome in adults:

Two 10 ml doses to be taken initially. The usual dose is between 4 mg (20 ml) and 8 mg (40 ml) per day in divided doses, depending on severity. If required, this dose can be adjusted according to result up to a maximum of 16 mg (80 ml) daily.

Use in Elderly:

No dose adjustment is required for the elderly.

Renal impairment

No dose adjustment is required for patients with renal impairment.

Hepatic impairment

Although no pharmacokinetic data are available in patients with hepatic impairment, Imodium should be used with caution in such patients because of reduced first pass metabolism. (see 4.4 Special warnings and special precautions for use).

Method of administration: Oral use.

4.3 Contraindications

Imo

increlex

10 mg/ml solution for injection
mecasermin

Read all of this leaflet carefully before you start using this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have further questions, please ask the doctor or pharmacist.
  • This medicine has been prescribed for you/your child. Do not pass it on to others. It may harm them, even if their symptoms are the same.
  • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell the doctor or pharmacist.

In this leaflet:

  • 1. What INCRELEX is and what it is used for
  • 2. Before you use INCRELEX
  • 3. How to use INCRELEX
  • 4. Possible side effects
  • 5. How to store INCRELEX
  • 6. Further information

What Increlex Is And What It Is Used For

  • INCRELEX is a liquid that contains man-made insulin-like growth factor-1 (IGF-1), which is similar to the IGF-1 made by your body.
  • INCRELEX is used to treat children or adolescents who are very short for their age because their bodies do not make enough IGF-1. This condition is called primary IGF-1 deficiency.

Before You Use Increlex

Do not use INCRELEX

  • if you/your child is allergic (hypersensitive) to mecasermin or any of the other ingredients of INCRELEX.
  • if you/your child has cancer.
  • by inject

1. Name Of The Medicinal Product

Ibandronic acid Sandoz 50 mg Film Coated Tablets

2. Qualitative And Quantitative Composition

Each film-coated tablet contains 50 mg of ibandronic acid (as ibandronic sodium monohydrate).

Excipients:

Each film-coated tablet contains 0.90 mg lactose monohydrate.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Film-coated tablets.

White round biconvex tablets

4. Clinical Particulars

4.1 Therapeutic Indications

Ibandronic acid Sandoz is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.

4.2 Posology And Method Of Administration

Ibandronic acid Sandoz therapy should only be initiated by physicians experienced in the treatment of cancer. For oral use.

The recommended dose is one 50 mg film-coated tablet daily.

Ibandronic acid Sandoz tablets should be taken after an overnight fast (at least 6 hours) and before the first food or drink of the day. Medicinal products and supplements (including calcium) should similarly be avoided prior to taking Ibandronic acid Sandoz tablets. Fasting should be continued for at least 30 minutes after taking the tablet. Plain water may be taken at any time during the course of Ibandronic acid Sandoz treatment.

- The tablets should be swallowed whole with a full glass of plain water (180 to 240 ml) while the patient is standing or sitting in an upright position.

- Patients should not lie down for 60 minutes after taking Ibandronic acid Sandoz.

- Patients should not chew, suck or crush the tablet

What You Should Know About Ibuleve Mousse

ibuprofen

Read these instructions carefully before use

About your treatment

The name of your treatment is Ibuleve Mousse. It contains 5.0% of ibuprofen as the active ingredient. It also contains the inactive ingredients propylene glycol, carbomer, phenoxyethanol, diethylamine and purified water. The ozone-friendly aerosol propellant is butane 40. The container holds 75 g of Ibuleve Mousse. It is a white, fragrance-free mousse which is non-sticky and non-greasy.

Ibuprofen is a proven non-steroidal anti-inflammatory drug (NSAID), which works by relieving pain, reducing swelling and easing inflammation. Ibuleve Mousse is designed to be rapidly absorbed into the skin for effective relief at the point of pain. The mousse also exerts a soothing and cooling effect when applied to the affected area.

IBULEVE MOUSSE IS MADE FOR THE MARKETING AUTHORISATION HOLDER

DIOMED DEVELOPMENTS LTD
HITCHIN
HERTS
SG4 7QR
UK

AT

PHARMASOL LTD
ANDOVER
HANTS
SP10 5AZ
UK

Your doctor or pharmacist has recommended or supplied Ibuleve Mousse for the relief of pain and inflammation in conditions such as:

  • Backache
  • Rheu

1. Name Of The Medicinal Product

Indivina 1 mg/2.5 mg tablets

Indivina 1 mg/5 mg tablets

Indivina 2 mg/5 mg tablets

2. Qualitative And Quantitative Composition

One Indivina 1 mg/2.5 mg tablet contains:

Estradiol valerate 1 mg

Medroxyprogesterone acetate 2.5 mg

Excipient: Lactose monohydrate 83mg

For a full list of excipients, see section 6.1.

One Indivina 1 mg/5 mg tablet contains:

Estradiol valerate 1 mg

Medroxyprogesterone acetate 5 mg

Excipient: Lactose monohydrate 80.5mg

For a full list of excipients, see section 6.1.

One Indivina 2 mg/5 mg tablet contains:

Estradiol valerate 2 mg

Medroxyprogesterone acetate 5 mg

Excipient: Lactose monohydrate 79.5mg

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Tablet.

White, round, bevelled-edge, diameter 7 mm, flat tablets with a code on one side with 1+2.5, 1+5 or 2+5.

4. Clinical Particulars

4.1 Therapeutic Indications

Hormone replacement therapy (HRT) for estrogen deficiency symptoms in women with an intact uterus more than three years after menopause.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

The experience of treating women older than 65 years is limited.

4.2 Posology And Method Of Administration

Indivina is a continuous combined HRT regimen in which estrogen and progestagen are given every day wit

What you should know about Isoniazid Ampoules

This leaflet contains information about Isoniazid Ampoules, which will be given to you (or your child) by injection. Although you will not be taking this medicine or giving it to your child yourself, this leaflet contains important information to help you understand how Isoniazid is used. Keep it until the course of treatment has been finished, as you may want to read it again.

Always follow your doctor`s advice, and if there is anything you do not understand, please ask your doctor or nurse to explain it.

What do Isoniazid Ampoules contain?

Each ampoule contains 50mg of Isoniazid (the active ingredient) together with two other ingredients which are as follows:

  • Hydrochloric Acid BP
  • Water for Injections BP

Isoniazid is supplied in packs of 10 ampoules, each ampoule coded with dark red and orange colour rings contains 2 ml.

Isoniazid is known as a `tuberculostatic drug`. This means that it stops the bacteria that cause tuberculosis from growing and multiplying. The body`s own defences can cope with the bacteria that are left, once the drug has stopped them reproducing.

The holder of the product licence for this medicine is

Cambridge Laboratories Limited
Deltic House
Kingfisher Way
Silverlink Business Park
Wallsend
Tyne & Wear
NE28 9NX

The ampoules are made by

1. Name Of The Medicinal Product

Indometacin Capsules BP 50mg

2. Qualitative And Quantitative Composition

Indometacin BP 50.00mg

3. Pharmaceutical Form

Capsules

4. Clinical Particulars

4.1 Therapeutic Indications

Indometacin is indicated for the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, and other rheumatic disorders. It is indicated in the treatment of acute gout.

Indometacin is also indicated in inflammation, pain and oedema following orthopaedic procedures and the treatment of pain and associated symptoms of primary dysmenorrhoea.

4.2 Posology And Method Of Administration

Route of administration: Oral

Recommended Dose and Dosage Schedules:

The usual dose is:-

Adults:

50-100mg increasing to 150-200mg daily in divided doses.

Elderly patients:

The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.

Children:

Contra-indicated, as paediatric dosage is not established.

To be taken preferably with or after food.

Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).

4.3 Contraindications

Contraindicated in children as a paediatric dose has not been established.

Contr

1. Name Of The Medicinal Product

Inderal Tablets 10 mg.

2. Qualitative And Quantitative Composition

Propranolol Hydrochloride Ph. Eur. 10 mg.

3. Pharmaceutical Form

Round pink film coated tablets.

4. Clinical Particulars

4.1 Therapeutic Indications

a) the control of hypertension;

b) the management of angina pectoris;

c) long term management against re-infarction after recovery from acute myocardial infarction;

d) the control of most forms of cardiac dysrhythmias;

e) the prophylaxis of migraine;

f) the management of essential tremor;

g) relief of situational anxiety and generalised anxiety symptoms, particularly those of somatic type;

h) prophylaxis of upper gastrointestinal bleeding in patients with portal hypertension and oesophageal varices;

i) the adjunctive management of thyrotoxicosis and thyrotoxic crisis;

j) management of hypertrophic obstructive cardiomyopathy;

k) management of phaeochromocytoma peri-operatively (with an alpha-blocker).

4.2 Posology And Method Of Administration

For oral administration

Adults

Hypertension

A starting dose of 80 mg twice a day may be increased at weekly intervals according to response. The usual dose range is 160 to 320 mg per day. With concurrent diuretic or other antihypertensive drugs a further reduction of blood pressure is obtained.

Angina, migraine and essential tremor

A starting dose of 40 mg two or three times daily may be increased by the same amount at weekly intervals acc

innohep 10,000 IU/ml

tinzaparin sodium

Please read all of this leaflet carefully before you start having this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If any of the side effects become serious, or you notice any side effects not listed in this leaflet please tell your doctor or pharmacist.
  • In this leaflet innohep 10,000 IU/ml will be called innohep.

In this leaflet:

  • 1. What innohep is and what it is used for
  • 2. Before you have innohep
  • 3. How to use innohep
  • 4. Possible side effects
  • 5. How to store innohep
  • 6. Further information

What Innohep Is And What It Is Used For

innohep belongs to a group of medicines called anticoagulants. It is a type of heparin called a low molecular weight heparin.

innohep changes the way your blood clots. This means your blood keeps flowing smoothly inside your blood vessels. These are the tubes that carry blood around your body and are called arteries and veins.

innohep is used to help stop:

  • Harmful blood clots forming in your veins following an operation.
    An example is a clot in a vein d